Year: 2021
Type: other
Abstract: Background: Mucopolysaccharidosis type III (MPS III or Sanfilippo syndrome) is a lysosomal storage disease resulting in progressive neurocognitive decline during childhood and early demise.Its diagnosis may have a great impact on parents, potentially leading to psychosocial problems such as anxiety, depression, parental distress, and posttraumatic stress.Methods: Twenty-six mothers and 19 fathers of 34 Dutch MPS III patients completed the 'Hospital Anxiety and Depression Scale' (HADS), the 'Distress Thermometer for Parents' (DT-P) and the 'Self Rating Scale for Posttraumatic Stress Disorders' (SRS-PTSD).Independent-sample t-tests and chi-square tests were used to assess differences between parents of MPS III patients and reference groups regarding anxiety and depression (HADS), distress (DT-P), and posttraumatic stress (SRS-PTSD).Results: Mothers met the criteria for clinically relevant anxiety (50%) and depression (34.6%) more frequently compared to reference mothers (p = 0.001).Fathers more often met the criteria for clinically relevant depression (36.8%) compared to reference fathers (p = 0.022).Clinically relevant distress was highly prevalent in mothers (84.6%) and fathers (68.4%) of MPS III patients compared to reference parents (p < 0.01).Finally, the prevalence of PTSD was strikingly higher in both mothers (26.9%) and fathers (15%) than reported in the general Dutch population (respectively p < 0.001 and p < 0.05).Conclusions: We report a clinically relevant impact of parenting an MPS III patient on psychosocial functioning, which is demonstrated by high levels of anxiety, depression, distress and a remarkably high prevalence of PTSD.Structural monitoring of the psychosocial functioning of MPS III parents is therefore essential and may be beneficial for the whole family.
Source: Pure Amsterdam UMC
Author: Conijn, Thirsa
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7011527390
